Article info

Download PDFPDF
Extended report
Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial

Authors

  1. Correspondence to Dr Nicola Dalbeth, Bone and Joint Research Group, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Rd, Grafton, Auckland 1023, New Zealand; n.dalbeth{at}auckland.ac.nz
View Full Text

Citation

Dalbeth N, Aati O, Gamble GD, et al
Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trial

Publication history

  • Received December 8, 2013
  • Revised January 2, 2014
  • Accepted January 3, 2014
  • First published January 17, 2014.
Online issue publication 
April 30, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.